These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3632394)

  • 1. Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit.
    DeSilva S; Drachman DB; Mellits D; Kuncl RW
    Arch Neurol; 1987 Aug; 44(8):818-22. PubMed ID: 3632394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.
    Fenichel GM; Florence JM; Pestronk A; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Robison J; King W
    Neurology; 1991 Dec; 41(12):1874-7. PubMed ID: 1745340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.
    Brooke MH; Fenichel GM; Griggs RC; Mendell JR; Moxley RT; Miller JP; Kaiser KK; Florence JM; Pandya S; Signore L
    Arch Neurol; 1987 Aug; 44(8):812-7. PubMed ID: 3632393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisone in Duchenne muscular dystrophy.
    Drachman DB; Toyka KV; Myer E
    Lancet; 1974 Dec; 2(7894):1409-12. PubMed ID: 4140328
    [No Abstract]   [Full Text] [Related]  

  • 5. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months).
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP; Cwik VA; Pandya S; Robison J
    Neurology; 1993 Mar; 43(3 Pt 1):520-7. PubMed ID: 8450994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP
    Arch Neurol; 1991 Apr; 48(4):383-8. PubMed ID: 2012511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
    Mendell JR; Moxley RT; Griggs RC; Brooke MH; Fenichel GM; Miller JP; King W; Signore L; Pandya S; Florence J
    N Engl J Med; 1989 Jun; 320(24):1592-7. PubMed ID: 2657428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies.
    Hussein G; Mansour L; Ghafar HA; Mostafa FA; Fawaz L
    J Investig Med; 2014 Aug; 62(6):875-9. PubMed ID: 24866459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.
    Fenichel GM; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Pestronk A; Robison J; King W; Signore L
    Arch Neurol; 1991 Jun; 48(6):575-9. PubMed ID: 2039377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Prednisone in Duchenne muscular dystrophy.
    Munsat TL; Walton JN
    Lancet; 1975 Feb; 1(7901):276-7. PubMed ID: 46418
    [No Abstract]   [Full Text] [Related]  

  • 11. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
    Wong BL; Christopher C
    J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.
    Connolly AM; Schierbecker J; Renna R; Florence J
    Neuromuscul Disord; 2002 Dec; 12(10):917-25. PubMed ID: 12467746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy.
    Kissel JT; Lynn DJ; Rammohan KW; Klein JP; Griggs RC; Moxley RT; Cwik VA; Brooke MH; Mendell JR
    Neurology; 1993 Mar; 43(3 Pt 1):532-6. PubMed ID: 8450996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prednisone in Duchenne dystrophy.
    Dubowitz V
    Neuromuscul Disord; 1991; 1(3):161-3. PubMed ID: 1822789
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.
    Tawil R; McDermott MP; Pandya S; King W; Kissel J; Mendell JR; Griggs RC
    Neurology; 1997 Jan; 48(1):46-9. PubMed ID: 9008492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal height and weight in a series of ambulant Duchenne muscular dystrophy patients using the 10 day on/10 day off prednisone regimen.
    ten Dam K; de Groot IJ; Noordam C; van Alfen N; Hendriks JC; Sie LT
    Neuromuscul Disord; 2012 Jun; 22(6):500-4. PubMed ID: 22390890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study.
    Reitter B
    Brain Dev; 1995; 17 Suppl():39-43. PubMed ID: 8882570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.
    Kissel JT; Burrow KL; Rammohan KW; Mendell JR
    Neurology; 1991 May; 41(5):667-72. PubMed ID: 2027481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [For the present Duchenne' disease should not be treated with prednisone].
    Jennekens FG; de Visser M; Wintzen AR; Wokke JH
    Ned Tijdschr Geneeskd; 1996 May; 140(21):1109-11. PubMed ID: 8692335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.